Harold Swerdlow

Harold received his PhD from the University of Utah in bioengineering and has been working on novel technology and instrumentation for biological applications since then. Currently, he is consulting for both Nuclera and Oxford Nanoimaging (ONI). Prior to that, he was VP of Sequencing for the New York Genome Center, Head of R&D for the Wellcome Trust Sanger Institute (Sanger Centre) and Senior Director of Research for Solexa Ltd. (now part of Illumina). He is a US Citizen, but a U.K. Permanent Resident.

Want to know more about our mission to change synthetic biology?

Our mission is simple: provide high-quality DNA at your benchtop.

Get in touch